Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials All patients with metastatic uveal melanoma ...

The uveal melanoma market is small but strategically important, driven by significant unmet medical needs, few available treatments, and growing innovation. Targeted therapies and immunotherapies, ...

Here is a breakdown of some of the important information surrounding uveal melanoma, an extremely rare form of cancer. Uveal melanoma is a rare form of eye cancer that many patients may not be aware ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Uveal Melanoma pipeline constitutes 25+ key companies continuously working towards developing 30+ Uveal Melanoma ...

iOnctura has announced promising results from the phase 1 DIONE-01 study, showcasing the clinical activity and long-term safety of roginolisib in patients with uveal melanoma. The data will be ...

Bilateral Diffuse Uveal Melanocytic Proliferation (BDUMP) is a rare paraneoplastic syndrome in which diffuse proliferation of melanocytes within the uveal tract leads to significant ocular morbidity.

An international, open-label trial demonstrated the overall survival benefits of administering tebentafusp to HLA-A*02:01-positive patients with metastatic uveal melanoma. A recent phase 3 trial ...

Researchers have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies. Uveal melanoma is a very aggressive type of melanoma that affects ...

Uveal melanoma is the most common primary malignancy of the eye and frequently leads to metastatic death. Until the mid-20th Century, the only treatment for uveal melanoma was enucleation. Since then, ...

Clinical trials seek to discover new ways to attack the disease, limit metastasis and prevent recurrence. JESSE WALDINGER'S tumor was found during an eye exam. Fortunately, it was discovered early and ...

Uveal melanoma is a rare tumour that has no established treatments once metastases develop. Although a variety of immune-based therapies have demonstrated some impressive responses in metastatic ...